Sameh Saber, Amr A. A. Mahmoud, Noha S. Helal, Eman El-ahwany and Rasha H. Abdelghany 2017. Losartan, an angiotensin-II type 1 receptor blocker, attenuates CCl4-induced liver fibrosis with a positive impact on survival in mice. World Journal of Pharmaceutical Sciences. 5, 12 (Dec. 2017), 121–126.